KYNDRA RUIZ: Open Payments
NPI 1649755356 · BURLESON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 21 payments from 8 companies in 2025. Trend: 2023 $482 · 2024 $372 · 2025 $507
Food & beverage: $507
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $146 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $130 |
| Impulse Dynamics (USA) Inc. | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Kestra Medical Technology Services, Inc. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| SCPHARMACEUTICALS INC. | 1 | $18 |
Products named: LEQVIO, LifeVest, Optimizer, JARDIANCE, ELIQUIS, Assure WCD, FARXIGA, FUROSCIX.
Industry payments across TX — which companies pay providers there.
